Cargando…

Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1

PURPOSE: ACT001 is a novel sesquiterpene lactone derivative with anticancer effects, including the reversal of tamoxifen resistance in estrogen receptor-positive breast cancer cells. However, few studies have investigated the anticancer effects of ACT001 in triple-negative breast cancer (TNBC), a hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanyang, Wang, Li, Liu, Jiewei, Xie, Xiaoxiao, Hu, Haoyue, Luo, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326172/ https://www.ncbi.nlm.nih.gov/pubmed/32617021 http://dx.doi.org/10.2147/CMAR.S244748

Ejemplares similares

Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB)
por: Yan, Fei, et al.
Publicado: (2020)

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
por: Kim, Eunju, et al.
Publicado: (2022)

Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
por: Shi, Xiaoyu, et al.
Publicado: (2023)

CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis
por: Liu, Xiu-fen, et al.
Publicado: (2011)

ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
por: Cai, Lin, et al.
Publicado: (2022)

Interleukin‐36α suppresses growth of non‐small cell lung cancer in vitro by reducing angiogenesis
por: Xie, Xiaoxiao, et al.
Publicado: (2021)

Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines
por: Wong, Fu Hou, et al.
Publicado: (2022)

Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells
por: Raman, Vishak, et al.
Publicado: (2017)

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2022)

Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway
por: Xu, Xiaohong, et al.
Publicado: (2019)

The RelB subunit of NFκB acts as a negative regulator of circadian gene expression
por: Bellet, Marina M., et al.
Publicado: (2012)

Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
por: Li, Ting, et al.
Publicado: (2014)

ADAM9 Mediates Triple-Negative Breast Cancer Progression via AKT/NF-κB Pathway
por: Zhou, Rui, et al.
Publicado: (2020)

Anthocyanidins Inhibit Growth and Chemosensitize Triple-Negative Breast Cancer via the NF-κB Signaling Pathway
por: Aqil, Farrukh, et al.
Publicado: (2021)

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
por: Wang, Yuyi, et al.
Publicado: (2018)

Suppression of NF-κB Reduces Myocardial No-Reflow
por: Zeng, Min, et al.
Publicado: (2012)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways
por: Liu, Yuping, et al.
Publicado: (2015)

Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway
por: Kuang, Wenbin, et al.
Publicado: (2023)

STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
por: Kuo, Wei-Ying, et al.
Publicado: (2017)

Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018)

Anticancer Activity of Novel NF-κB Inhibitor DHMEQ by Intraperitoneal Administration
por: Umezawa, Kazuo, et al.
Publicado: (2020)

Ovatodiolide of Anisomeles indica Exerts the Anticancer Potential on Pancreatic Cancer Cell Lines through STAT3 and NF-κB Regulation
por: Hsieh, Ya-Ju, et al.
Publicado: (2016)

Heparanase from triple-negative breast cancer and platelets acts as an enhancer of metastasis
por: Yang, Wen-Jing, et al.
Publicado: (2020)

Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel
por: Plett, Riley, et al.
Publicado: (2022)

In vitro and in vivo anticancer activity of Lycorine in prostate cancer by inhibiting NF-κB signaling pathway
por: Liu, Jie, et al.
Publicado: (2022)

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice
por: Liu, C, et al.
Publicado: (2015)

GPR108, an NF-κB activator suppressed by TIRAP, negatively regulates TLR-triggered immune responses
por: Dong, Danfeng, et al.
Publicado: (2018)

Suppression of Invasion and Metastasis of Triple-Negative Breast Cancer Lines by Pharmacological or Genetic Inhibition of Slug Activity()()()
por: Ferrari-Amorotti, Giovanna, et al.
Publicado: (2014)

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer
por: Buckley, Niamh E., et al.
Publicado: (2016)

Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
por: Kanzaki, Hirotaka, et al.
Publicado: (2021)

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
por: Dardis, Gabrielle J., et al.
Publicado: (2023)

The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
por: Varghese, Elizabeth, et al.
Publicado: (2018)

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021)

10Z-Hymenialdisine inhibits angiogenesis by suppressing NF-κB activation in pancreatic cancer cell lines
por: Ueda, Goro, et al.
Publicado: (2022)

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
por: Seubwai, Wunchana, et al.
Publicado: (2016)

Several Alphaherpesviruses Interact Similarly with the NF-κB Pathway and Suppress NF-κB-Dependent Gene Expression
por: Romero, Nicolás, et al.
Publicado: (2023)

Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity
por: Zhao, Hongjuan, et al.
Publicado: (2015)

ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells
por: Kaochar, Salma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kcccvbtijik8ur15rrh1p4d6eh